Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 2/2007

Sonderheft 2/2007

Controversies in breast cancer

Inhaltsverzeichnis ( 28 Artikel )

01.12.2007 | Review | Sonderheft 2/2007

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden, Sarah Bacus

01.12.2007 | Preface | Sonderheft 2/2007

Preface: controversies in breast cancer

01.12.2007 | Section introduction | Sonderheft 2/2007

Psychosocial controversies in breast cancer

01.12.2007 | Short communication | Sonderheft 2/2007

The case for user involvement in research: the research priorities of cancer patients

01.12.2007 | Short communication | Sonderheft 2/2007

Why patient representation might harm science?

01.12.2007 | Short communication | Sonderheft 2/2007

A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget

01.12.2007 | Short communication | Sonderheft 2/2007

Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?

01.12.2007 | Short communication | Sonderheft 2/2007

Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer

01.12.2007 | Short communication | Sonderheft 2/2007

Decision making in local therapy for breast cancer

01.12.2007 | Short communication | Sonderheft 2/2007

Benefits of complementary therapies

01.12.2007 | Short communication | Sonderheft 2/2007

The dangers of complementary therapy

01.12.2007 | Section introduction | Sonderheft 2/2007

Introduction to sessions on Personalising treatment

01.12.2007 | Short communication | Sonderheft 2/2007

Personalized surgical treatment of breast cancer

01.12.2007 | Short communication | Sonderheft 2/2007

Short-term presurgical treatment for all?

01.12.2007 | Short communication | Sonderheft 2/2007

Adjuvant treatment: the contribution of expression microarrays

01.12.2007 | Short communication | Sonderheft 2/2007

Current and future choices in endocrine therapy

01.12.2007 | Section introduction | Sonderheft 2/2007

Introduction: challenging established dogma

01.12.2007 | Short communication | Sonderheft 2/2007

Does presurgical treatment destroy important prognostic information

01.12.2007 | Short communication | Sonderheft 2/2007

Surrogates are just surrogates, but helpful just the same

01.12.2007 | Short communication | Sonderheft 2/2007

Do classical oestrogen markers predict for clinical response to endocrine therapy?

01.12.2007 | Short communication | Sonderheft 2/2007

The origins of oestrogen receptor negative breast cancer

01.12.2007 | Short communication | Sonderheft 2/2007

The oestrogen paradox: an hypothesis

01.12.2007 | Short communication | Sonderheft 2/2007

Oestrogen is bad for patients with breast cancer?

01.12.2007 | Section introduction | Sonderheft 2/2007

Introduction to clinical research sessions

01.12.2007 | Short communication | Sonderheft 2/2007

Oxford Overview

01.12.2007 | Short communication | Sonderheft 2/2007

Endocrine and targeted treatments for breast cancer

01.12.2007 | Short communication | Sonderheft 2/2007

Clinical outcomes: to be a surrogate or not to be ...?

01.12.2007 | Short communication | Sonderheft 2/2007

Metabolic approaches to breast cancer treatment and prevention

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise